‘We are motivated by the FDA’s contract on the trial design and planned analysis, and appearance forward to further developing laquinimod as a potential treatment choice for RRMS patients.’.. Energetic Biotech, Teva to commence third Phase III study of laquinimod for RRMS Teva Pharmaceutical Sectors Ltd. and Active Biotech provided today an upgrade on the clinical development system of once-daily oral laquinimod for the treatment of relapsing-remitting multiple sclerosis .But a new study shows that surgery to cope with chronically stuffed sinuses can help people breathe and rest better, including people who have sleep apnea. The study discovered that 15 % of people with chronically stuffed sinuses also had the sleep disorder obstructive sleep apnea. After surgery to very clear the sinuses, people reported better standard of living and improved sleep, whether or not or not that they had a sleep disorder. Poor rest, feeling tired, and exhaustion are all frequent complaints of individuals with chronic sinus disease, said study author Dr.